Cargando…

Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation

AIM: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hairong, Lu, Jiaming, He, Furong, Wang, Mei, Yan, Yunbo, Chen, Binyang, Xie, De, Xu, Chenxi, Wang, Qiang, Liu, Weidong, Yu, Wei, Xi, Yuemei, Yu, Linqian, Yamamoto, Tetsuya, Koyama, Hidenori, Wang, Wei, Zhang, Chenggui, Cheng, Jidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513153/
https://www.ncbi.nlm.nih.gov/pubmed/36177037
http://dx.doi.org/10.3389/fimmu.2022.931087
_version_ 1784797993476554752
author Zhao, Hairong
Lu, Jiaming
He, Furong
Wang, Mei
Yan, Yunbo
Chen, Binyang
Xie, De
Xu, Chenxi
Wang, Qiang
Liu, Weidong
Yu, Wei
Xi, Yuemei
Yu, Linqian
Yamamoto, Tetsuya
Koyama, Hidenori
Wang, Wei
Zhang, Chenggui
Cheng, Jidong
author_facet Zhao, Hairong
Lu, Jiaming
He, Furong
Wang, Mei
Yan, Yunbo
Chen, Binyang
Xie, De
Xu, Chenxi
Wang, Qiang
Liu, Weidong
Yu, Wei
Xi, Yuemei
Yu, Linqian
Yamamoto, Tetsuya
Koyama, Hidenori
Wang, Wei
Zhang, Chenggui
Cheng, Jidong
author_sort Zhao, Hairong
collection PubMed
description AIM: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of type 2 diabetes mellitus (T2DM). However, the effect of HUA on glucose uptake and the insulin sensitivity of macrophages and its mechanism is unclear. METHODS: To assess systemic IR, we generated hyperuricemic mice by urate oxidase knockout (UOX-KO). Then, glucose/insulin tolerance, the tissue uptake of 18F-fluorodeoxyglucose, body composition, and energy balance were assessed. Glucose uptake of circulating infiltrated macrophages in the liver was evaluated by glucose transporter type 4 (GLUT-4) staining. Insulin sensitivity and the insulin signaling pathway of macrophages were demonstrated using the 2-NBDG kit, immunoblotting, and immunofluorescence assays. The immunoprecipitation assay and LC-MS analysis were used to determine insulin receptor substrate 2 (IRS2) levels and its interacting protein enrichment under HUA conditions. RESULTS: Compared to WT mice (10 weeks old), serum uric acid levels were higher in UOX-KO mice (WT, 182.3 ± 5.091 μM versus KO, 421.9 ± 45.47 μM). Hyperuricemic mice with metabolic disorders and systemic IR showed inflammatory macrophage recruitment and increased levels of circulating proinflammatory cytokines. HUA inhibited the nuclear translocation of GLUT-4 in hepatic macrophages, restrained insulin-induced glucose uptake and glucose tolerance, and blocked insulin IRS2/PI3K/AKT signaling. Meanwhile, HUA mediated the IRS2 protein degradation pathway and activated AMPK/mTOR in macrophages. LC-MS analysis showed that ubiquitination degradation could be involved in IRS2 and its interacting proteins to contribute to IR under HUA conditions. CONCLUSION: The data suggest that HUA-induced glucose intolerance in hepatic macrophages contributed to insulin resistance and impaired the insulin signaling pathway via IRS2-proteasome degradation
format Online
Article
Text
id pubmed-9513153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95131532022-09-28 Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation Zhao, Hairong Lu, Jiaming He, Furong Wang, Mei Yan, Yunbo Chen, Binyang Xie, De Xu, Chenxi Wang, Qiang Liu, Weidong Yu, Wei Xi, Yuemei Yu, Linqian Yamamoto, Tetsuya Koyama, Hidenori Wang, Wei Zhang, Chenggui Cheng, Jidong Front Immunol Immunology AIM: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of type 2 diabetes mellitus (T2DM). However, the effect of HUA on glucose uptake and the insulin sensitivity of macrophages and its mechanism is unclear. METHODS: To assess systemic IR, we generated hyperuricemic mice by urate oxidase knockout (UOX-KO). Then, glucose/insulin tolerance, the tissue uptake of 18F-fluorodeoxyglucose, body composition, and energy balance were assessed. Glucose uptake of circulating infiltrated macrophages in the liver was evaluated by glucose transporter type 4 (GLUT-4) staining. Insulin sensitivity and the insulin signaling pathway of macrophages were demonstrated using the 2-NBDG kit, immunoblotting, and immunofluorescence assays. The immunoprecipitation assay and LC-MS analysis were used to determine insulin receptor substrate 2 (IRS2) levels and its interacting protein enrichment under HUA conditions. RESULTS: Compared to WT mice (10 weeks old), serum uric acid levels were higher in UOX-KO mice (WT, 182.3 ± 5.091 μM versus KO, 421.9 ± 45.47 μM). Hyperuricemic mice with metabolic disorders and systemic IR showed inflammatory macrophage recruitment and increased levels of circulating proinflammatory cytokines. HUA inhibited the nuclear translocation of GLUT-4 in hepatic macrophages, restrained insulin-induced glucose uptake and glucose tolerance, and blocked insulin IRS2/PI3K/AKT signaling. Meanwhile, HUA mediated the IRS2 protein degradation pathway and activated AMPK/mTOR in macrophages. LC-MS analysis showed that ubiquitination degradation could be involved in IRS2 and its interacting proteins to contribute to IR under HUA conditions. CONCLUSION: The data suggest that HUA-induced glucose intolerance in hepatic macrophages contributed to insulin resistance and impaired the insulin signaling pathway via IRS2-proteasome degradation Frontiers Media S.A. 2022-09-13 /pmc/articles/PMC9513153/ /pubmed/36177037 http://dx.doi.org/10.3389/fimmu.2022.931087 Text en Copyright © 2022 Zhao, Lu, He, Wang, Yan, Chen, Xie, Xu, Wang, Liu, Yu, Xi, Yu, Yamamoto, Koyama, Wang, Zhang and Cheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhao, Hairong
Lu, Jiaming
He, Furong
Wang, Mei
Yan, Yunbo
Chen, Binyang
Xie, De
Xu, Chenxi
Wang, Qiang
Liu, Weidong
Yu, Wei
Xi, Yuemei
Yu, Linqian
Yamamoto, Tetsuya
Koyama, Hidenori
Wang, Wei
Zhang, Chenggui
Cheng, Jidong
Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
title Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
title_full Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
title_fullStr Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
title_full_unstemmed Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
title_short Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
title_sort hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via irs2-proteasome degradation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513153/
https://www.ncbi.nlm.nih.gov/pubmed/36177037
http://dx.doi.org/10.3389/fimmu.2022.931087
work_keys_str_mv AT zhaohairong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT lujiaming hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT hefurong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT wangmei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT yanyunbo hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT chenbinyang hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT xiede hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT xuchenxi hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT wangqiang hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT liuweidong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT yuwei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT xiyuemei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT yulinqian hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT yamamototetsuya hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT koyamahidenori hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT wangwei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT zhangchenggui hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation
AT chengjidong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation